SEC Form 4 · accession 0001127602-18-000896
HAEMONETICS CORP · HAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark W Kroll
Director
Period of report
Jan 2, 2018
Accepted (ET)
Jan 3, 2018 · 8:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000313143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 2, 2018 | M | 7,118 | $34.405 | A | 33,881 | D | |
| Common Stock | Jan 2, 2018 | S | 7,118 | $63.00 | D | 26,763 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Buy)F2 | $34.405 | Jan 2, 2018 | M | 7,118 | D | Jul 21, 2012 | Jul 21, 2018 | Common Stock | 7,118 | 0 | D |
Explanation of responses
- F1Exercise and sale pursuant to a trading plan which was established consistent with the requirements of Rule 10b5-1.
- F2Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.